Your browser doesn't support javascript.
Low Rate of SARS-CoV-2 Infection in Adults With Active Cancer Diagnosis in a Nonendemic Region in the United States.
Puckett, Yana; Wilke, Lee; Weber, Sharon; Parkes, Amanda; LoConte, Noelle K.
  • Puckett Y; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, puckettyana@gmail.com.
  • Wilke L; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Weber S; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Parkes A; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • LoConte NK; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
WMJ ; 119(4): 286-288, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1017548
ABSTRACT

INTRODUCTION:

The mortality rate in cancer patients with SARS-CoV-2 has been cited to be as high as 13% amidst a global pandemic. Here we present the prevalence of SARS-CoV-2 in adult patients with active cancer in a nonendemic cancer center at the time of the study.

METHODS:

All adult patients with an active history of cancer undergoing any elective surgery were screened for SARS-CoV-2 symptoms, including fever ≥ 38 degrees Celsius, chills, dyspnea, cough, sputum production, pharyngitis, myalgia/arthralgia, headache, anosmia, and nasal discharge. Both symptomatic and asymptomatic patients were tested for SARS-CoV-2 preoperatively via nasopharyngeal swab within 48 hours of surgery using an RT-PCR assay. Active cancer was defined as receipt of chemotherapy and/or radiation within 1 year of the SARS-CoV-2 test. Deidentified, institutional review board-exempt patient data were analyzed with IBM Statistical Package for the Social Sciences (SPSS) Version 26.

RESULTS:

Between March 16, 2020 and June 30, 2020, a total of 227 patients were tested preoperatively for SARS-CoV-2. Median age was 64.0 years (range 21 to 90). The majority of the cohort were White. Only 2 patients (0.8%) were positive for SARS-CoV-2. One 73-year-old woman undergoing hip replacement had Stage IV breast cancer and a 75-year-old man undergoing port placement had Stage IV retroperitoneal leiomyosarcoma. Neither patient had symptoms of SARS-CoV-2, underwent hospitalization for SARS-CoV-2, or proceeded to have the scheduled surgery after the positive test results until a 14-day quarantine period and a subsequent negative test result. Both patients subsequently received the procedures they were originally scheduled for with no complications.

CONCLUSION:

Careful consideration of resource allocation and treatment limitations for cancer patients should occur in lower endemic regions.
Subject(s)
Search on Google
Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Case report / Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: WMJ Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Case report / Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: WMJ Journal subject: Medicine Year: 2020 Document Type: Article